Literature DB >> 9432369

Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.

A Laszlo1, M Rahman, M Raviglione, F Bustreo.   

Abstract

SETTING: Quality assurance of the WHO/IUATLD global tuberculosis drug resistance surveillance programme.
OBJECTIVE: To perform a proficiency test of drug susceptibility procedures within the WHO/IUATLD network of supranational reference laboratories (SRL).
DESIGN: Identical culture panels consisting of 20 clinical isolates of Mycobacterium tuberculosis containing both drug susceptible and drug resistant cultures were tested by the 16 laboratories of the network for resistance to streptomycin, isoniazid, rifampicin and ethambutol. The drug susceptibility testing procedures included the proportion, absolute concentration and resistance ratio methods as well as their variants, including the radiometric BACTEC 460 method.
RESULTS: The first round of proficiency testing has shown that the specificity of drug susceptibility testing within the SRL network was significantly higher than its sensitivity. The testing of isoniazid and rifampicin shows a high degree of agreement between the labs, but discordant results can be obtained with streptomycin and ethambutol.
CONCLUSION: Drug susceptibility procedures for the testing of isoniazid and rifampicin, the two anti tuberculosis drugs which define multidrug-resistant tuberculosis, are highly reliable within the SRL network. Procedures for drug susceptibility testing of streptomycin and ethambutol are still in need of standardization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9432369

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  24 in total

1.  Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.

Authors:  V Goloubeva; M Lecocq; P Lassowsky; F Matthys; F Portaels; I Bastian
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 2.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

3.  Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Authors:  I Bastian; L Rigouts; J C Palomino; F Portaels
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Authors:  Pawan K Angra; Thomas H Taylor; Michael F Iademarco; Beverly Metchock; J Rex Astles; John C Ridderhof
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

Review 5.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.

Authors:  Jian Du; Wei Shu; Yuhong Liu; Yufeng Wang; Ying Zhan; Kexin Yu; Jingtao Gao; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-24       Impact factor: 3.267

7.  Spread of drug-resistant pulmonary tuberculosis in Estonia.

Authors:  A Krüüner; S E Hoffner; H Sillastu; M Danilovits; K Levina; S B Svenson; S Ghebremichael; T Koivula; G Källenius
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Thomas Bodmer; Juerg Munzinger; Monique Perrin; Véronique Vincent; Henri Drugeon
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures.

Authors:  H Syre; S Phyu; P Sandven; B Bjorvatn; H M S Grewal
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe.

Authors:  Isabelle Devaux; Kristin Kremer; Herre Heersma; Dick Van Soolingen
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.